Idrasil® will harness the medicinal analgesic and therapeutic benefits while effectively removing the negative connotations and social stigmas. Idrasil® is an effective, non-addictive, non-opioid pain management option specifically targeted toward valid patient ailments.

About Idrasil

Idrasil® is the first standardized form of medical cannabis. Idrasil® has a consistent formula that allows physicians and caregivers the ability to provide patients with a measurable dosage.

Idrasil® provides all of the medicinal analgesic & therapeutic benefits of Medical Cannabis without the social risks associated with smoking or the unpredictable dosages of edible confections. Idrasil® eliminates the negative social stigmas associated with Medical Marijuana and replaces them with a mainstream ALL NATURAL NUTRACEUTICAL which looks like any other pill on the market.

Cannabinoids are the active components of Cannabis. Tetrahydrocannabinol (THC) & Cannabidiol (CBD) are the most prevalent natural cannabinoids and have received the most study, however, Idrasil® contains over 65 cannabinoids. Unlike Marinol (Dronabinol), which are synthetic forms of a single cannabinoid (THC) only, Idrasil® is an all-natural cannabis plant extract containing the full spectrum of naturally occurring cannabinoids (cannabis).



Steele Clarke Smith
CEO at Idrasil™
Theresa Smith
President at C3 International, Inc.